Wearable Technology Use Low in MS Despite High Intention of Use

Why It Matters

The gap limits the potential of remote monitoring to improve MS management, signaling a need for tailored strategies to boost real‑world adoption.

Key Takeaways

• Only 34% of MS patients wear wearables regularly
• Trust and anxiety predict intention to use technology
• Higher symptom severity reduces actual wearable adoption
• Social influence modestly impacts behavioral intention
• AI health app usage even lower among MS patients

Pulse Analysis

The rise of digital health tools has transformed chronic disease management, offering continuous data streams that can inform treatment decisions. In multiple sclerosis, where fatigue, cognitive fluctuations, and motor impairments vary day to day, wearables promise early detection of relapses and personalized therapy adjustments. Yet the technology’s value hinges on consistent patient engagement, a factor that remains elusive for many MS sufferers.

The study’s data reveal a stark intention‑behavior gap: while MS patients reported similar willingness to adopt wearables as peers with other conditions, actual regular use lagged dramatically. Trust in the device, anxiety about technology, and perceived social endorsement emerged as key drivers of intent, whereas higher symptom severity—particularly cognitive load—dampened real‑world adoption. Compared with a small non‑MS cohort, MS participants were markedly less likely to use AI‑powered health apps, underscoring broader apprehensions about digital interventions.

For developers and clinicians, these insights suggest a multi‑pronged approach. Building transparent data security, simplifying user interfaces, and offering education can alleviate anxiety and foster trust. Integrating wearable data into routine clinical visits may enhance perceived social influence and demonstrate tangible benefits, encouraging sustained use. Policymakers should consider reimbursement models that reward adherence, while future research must link acceptance metrics to clinical outcomes to prove the true value of wearables in MS care.